American Diabetes Association Says Mifepristone Shown To Reduce A1C In Patients With Difficult-To-Control Type 2 Diabetes And Hypercortisolism
Refinitiv閱讀少於1分鐘
AMERICAN DIABETES ASSOCIATION: MIFEPRISTONE SHOWN TO REDUCE A1C IN PATIENTS WITH DIFFICULT-TO-CONTROL TYPE 2 DIABETES AND HYPERCORTISOLISM
登入或建立一個永久免費帳戶來閱讀此新聞